Since the initial discovery of ALS-associated mutations in FUS, attention has focused on the possibility that loss of one or more of the many functions of this essential regulatory protein in transcriptional regulation, pre-mRNA splicing, RNA processing and RNA localization might lead to selective neurodegeneration in ALS and FTD. This evidence concerns the gene FUS and frontotemporal dementia.